Carisma Therapeutics Inc.
CARMDelisted Dec 15, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001485003
Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Carisma Therapeutics Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +5 vs. Q3 2024
- Shares held
- 5.62M
- +1.67M (+42.2%) vs. Q3 2024
- Total value
- $2.35M
- −$1.53M (−39.3%) vs. Q3 2024
- New holders
- 14
- 5 more added
- Sold out
- 9
- 7 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CARM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $4 |
| Q1 2026 | 3 | $47.9K |
| Q4 2025 | 7 | $67.0K |
| Q3 2025 | 33 | $842.6K |
| Q2 2025 | 36 | $1.56M |
| Q1 2025 | 37 | $1.73M |
| Q4 2024 | 41 | $2.35M |
| Q3 2024 | 37 | $5.11M |
| Q2 2024 | 53 | $9.28M |
| Q1 2024 | 51 | $19.3M |
| Q4 2023 | 50 | $26.4M |
| Q3 2023 | 58 | $39.6M |
| Q2 2023 | 53 | $84.0M |
| Q1 2023 | 37 | $17.3M |
| Q4 2022 | 71 | $19.8M |
| Q3 2022 | 69 | $11.0M |
| Q2 2022 | 74 | $23.1M |
| Q1 2022 | 84 | $26.4M |
| Q4 2021 | 93 | $39.1M |
| Q3 2021 | 103 | $44.5M |
| Q2 2021 | 106 | $305.9M |
| Q1 2021 | 76 | $104.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Carisma Therapeutics Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 10 | $4 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 31 | $13 | 0.00% | +31 | New |
| Harbour Investments, Inc. | 37 | $15 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 50 | $21 | 0.00% | −115−69.7% | Reduced |
| Medallion Wealth Advisors, LLC | 100 | $31 | 0.00% | +100 | New |
| Advisor Group Holdings, Inc. | 142 | $59 | 0.00% | 00.0% | Unchanged |
| Carolina Wealth Advisors, LLC | 150 | $63 | 0.00% | +150 | New |
| ORG Partners LLC | 200 | $83 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 206 | $86 | 0.00% | 00.0% | Unchanged |
| Peoples Bank | 250 | $102 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 467 | $196 | 0.00% | +467 | New |
| Bank & Trust Co | 525 | $220 | 0.00% | 00.0% | Unchanged |
| Union Bancaire Privee, UBP SA | 535 | $227 | 0.00% | +535 | New |
| JPMorgan Chase & Co | 921 | $386 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2,230 | $934 | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 4,973 | $2.08K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,685 | $2.38K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 7,277 | $3.04K | 0.00% | −4−0.1% | Reduced |
| Tower Research Capital LLC (TRC) | 7,827 | $3.28K | 0.00% | +3,303+73.0% | Added |
| Baader Bank INC | 11,804 | $4.42K | 0.00% | +11,804 | New |
| Two Sigma Securities, LLC | 11,432 | $4.79K | 0.00% | +11,432 | New |
| Stratos Wealth Partners, LTD. | 12,200 | $5.11K | 0.00% | 00.0% | Unchanged |
| Dynamic Financial Group | 15,350 | $6.43K | 0.01% | +15,350 | New |
| Virtu Financial LLC | 17,327 | $7.00K | 0.00% | +17,327 | New |
| LPL Financial LLC | 20,895 | $8.75K | 0.00% | +20,895 | New |
| Goldman Sachs Group Inc | 21,381 | $8.95K | 0.00% | +21,381 | New |
| Blodgett Wealth Advisors, LLC | 24,001 | $10.1K | 0.01% | −1,000−4.0% | Reduced |
| UBS Group AG | 24,301 | $10.2K | 0.00% | +24,083+11,047.2% | Added |
| Bridgeway Capital Management, LLC | 30,988 | $13.0K | 0.00% | +550+1.8% | Added |
| Empowered Funds, LLC | 30,988 | $13.0K | 0.00% | +550+1.8% | Added |
| HRT Financial LP | 36,902 | $15.0K | 0.00% | +36,902 | New |
| Northern Trust Corp | 69,888 | $29.3K | 0.00% | −5,563−7.4% | Reduced |
| State Street Corp | 85,106 | $35.6K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 120,157 | $50.3K | 0.00% | −22,365−15.7% | Reduced |
| Renaissance Technologies LLC | 231,357 | $96.9K | 0.00% | +24,600+11.9% | Added |
| Geode Capital Management, LLC | 259,184 | $108.6K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 408,147 | $170.9K | 0.00% | −417−0.1% | Reduced |
| Barclays PLC | 549,305 | $230.0K | 0.00% | 00.0% | Unchanged |
| AJU IB Investment Co., Ltd. | 718,332 | $300.8K | 0.29% | +718,332 | New |
| Vanguard Group Inc | 1,418,848 | $594.5K | 0.00% | −29,399−2.0% | Reduced |
| Merck & Co., Inc. | 1,473,240 | $617.0K | 0.24% | +1,473,240 | New |
| TPG GP A, LLC | 0 | $0 | 0.00% | −561,442−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −34,861−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −34,141−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −16,584−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −3,900−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −736−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −161−100.0% | Sold out |
| McMahon Financial Advisors, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Trustees of the University of Pennsylvania | – | – | – | – | Not filed |